top of page

discussion panels

Discussion Panel I: 21 Jul 2021, 10:00 am - 11:00 am

Discussion Panel II: 26 Jul 2021, 8:00 pm - 9:30 pm

meet our speakers!


Dr. Zubin Daruwalla


A/Prof Daniel Ting

Jeremy Lim.jpeg

A/Prof Jeremy Lim

Dean Ho Photo.jpg

Prof Dean Ho

Mr Teo Cher Hwa.jpg

Mr. Teo Cher Hwa

Jasmine Ong.jpg

Ms. Jasmine Ong


21 Jul, 10:00 am - 11:00 am

Discussion Panel I: Future of Healthtech

Panelists: Dr Zubin Daruwalla (PwC), A/Prof Jeremy Lim (SSHSPH),

Mr Teo Cher Hwa (NHIC)

26 Jul, 8:00 pm - 9:30 pm

Discussion Panel II: Ethical challenges of AI-driven healthcare

Panelists:  A/Prof Daniel Ting (SingHealth), Prof Dean Ho (N.1 Institute for Health), Ms Jasmine Ong (SGH) 

about the event

Discussion Panel I: Future of HealthTech

The Global Burden of Disease 2017 estimates indicate that people in Singapore are living longer & healthier lives than most people around the world, however these later years are spent coping with a multitude of age-related health problems. In the face of the impending burden of chronic disease and eldercare, how can technology drive healthcare innovation to empower individuals to take charge of their own health, revolutionise our current processes, and transform our healthcare system?


This discussion will explore various themes including:

  1. Pain points in the healthcare arena and future issues that will need to be tackled (disease diagnosis and treatment, healthcare delivery, healthcare financing, etc.)

  2. How can HealthTech serve to alleviate/mitigate these issues and how has its integration into Singapore's healthcare ecosystem evolved over time (key players/movers involved, types of interventions, etc.)

  3. Projected Trends in the HealthTech space and how students can get involved/be prepared to enter

Discussion Panel II: Ethical challenges of AI-driven healthcare

Artificial intelligence is the latest darling of the healthtech industry, with existing clinical applications ranging from imaging, diagnostics, and predictive interventions. With growth metrics forecasting a market size of 45 billion USD by 2026, it is without a doubt that AI in healthcare will be a strong driver of the healthtech industry. 


However this growth is not without controversy, and there are multiple challenges to the adoption of AI and machine learning algorithms, especially within the highly sensitive sphere of patient care. These include issues that largely center around patient privacy, data consent and usage, and perhaps most importantly algorithmic partiality and bias.


To shed light on these issues, we have assembled a star-studded panel of guests that actively blend the use of AI and clinical decision making in their everyday practice. Join our guests, A/Prof Daniel Ting, Prof Dean Ho, Ms. Jasmine Ong… as they delve into the ethical intricacies of AI in healthtech and clinical practice!


This panel will explore the topics on:

  1. What are some examples of AI-driven healthcare and it’s integration in the local healthcare landscape?

  2. In making fair and unbiased clinical judgments, how does AI fare compared to clinicians?

  3. How do we ensure informed consent of data use and protect patient privacy in the age of Big Data Analytics and AI/ML

bottom of page